Mimedx Group Inc (MDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 348,879 | 321,477 | 267,841 | 242,019 | 248,234 |
| Cost of Goods | 60,073 | 54,634 | 48,316 | 39,628 | 39,330 |
| Gross Profit | 288,806 | 266,843 | 219,525 | 202,391 | 208,904 |
| Operating Expenses | 230,014 | 230,361 | 234,568 | 210,070 | 254,632 |
| Operating Income | 58,865 | 37,116 | -14,727 | -7,051 | -45,398 |
| Interest Expense | 1,006 | 6,457 | 5,016 | 4,980 | 7,941 |
| Other Income | -565 | -26 | -4 | -23 | -8,204 |
| Pre-tax Income | 57,294 | 30,633 | -19,747 | -12,054 | -61,543 |
| Income Tax | 15,296 | -36,806 | 206 | 247 | -12,259 |
| Net Income Continuous | 41,998 | 67,439 | -19,953 | -12,301 | -49,284 |
| Net Income Discontinuous | 421 | -9,211 | -10,244 | 2,016 | N/A |
| Net Income | $42,419 | $58,228 | $-30,197 | $-10,285 | $-49,284 |
| EPS Basic Total Ops | 0.29 | 0.40 | -0.33 | -0.15 | -0.77 |
| EPS Basic Continuous Ops | 0.29 | 0.48 | -0.24 | -0.11 | -0.46 |
| EPS Basic Discontinuous Ops | 0.00 | -0.08 | -0.09 | 0.02 | N/A |
| EPS Diluted Total Ops | 0.28 | 0.37 | -0.33 | -0.15 | -0.77 |
| EPS Diluted Continuous Ops | 0.28 | 0.43 | -0.24 | -0.11 | -0.46 |
| EPS Diluted Discontinuous Ops | 0.00 | -0.06 | -0.09 | 0.02 | N/A |
| EPS Diluted Before Non-Recurring Items | 0.29 | 0.10 | -0.33 | -0.15 | -0.77 |
| EBITDA(a) | $64,906 | $40,543 | $-10,681 | $-813 | $-36,267 |